The Role of Medication Data to Enhance the Prediction of Alzheimer’s Progression Using Machine Learning

Table 1

Patients’ statistics at baseline.

	sMCI (n = 363)	pMCI (n = 106)	AD (n = 318)	Combined (n = 1036)
Sex (M/F)	210/153	44/62	142/176	483/553
Age (years)	72.92  07.76	73.89  06.84	75.01  07.81	73.82  07.18
Education	15.80  02.97	16.13  02.71	15.13  02.98	15.85  02.90
FAQ	02.64  03.31	07.63  04.49	16.42  06.59	06.81  08.01
MMSE	27.62  01.95	25.46  01.84	20.95  03.95	25.66  04.17
MoCA	22.96  02.21	20.69  01.84	17.11  03.43	21.56  04.14
APOE4	00.51  00.66	00.85  00.71	00.85  00.71	00.56  00.67
ADAS 13	14.69  06.71	22.69  05.29	33.59  09.39	19.73  12.24
ADAS 11	09.18  04.47	14.25  03.90	22.82  08.09	12.96  08.88
CDRSB	01.42  00.79	02.99  01.19	05.99  02.49	02.67  02.79

Data are mean standard deviation.